Image for cardiac allograft vasculopathy

cardiac allograft vasculopathy

Cardiac allograft vasculopathy (CAV) is a condition that can occur after a heart transplant. It involves the narrowing and hardening of the blood vessels in the transplanted heart, similar to coronary artery disease. This happens because the body’s immune system responds to the new heart, leading to damage in the blood vessel walls. CAV can reduce blood flow to the heart muscle, increasing the risk of heart problems. Regular monitoring and treatment are essential to manage this condition and help ensure the long-term success of the heart transplant.

Additional Insights

  • Image for cardiac allograft vasculopathy

    Cardiac Allograft Vasculopathy (CAV) is a condition that affects heart transplant recipients. It involves the narrowing of the arteries in the transplanted heart, similar to how heart disease develops in people with cardiovascular risk factors. This narrowing can occur due to the body's immune response to the new organ, causing inflammation and scarring over time. CAV can lead to serious complications, including heart failure, and is often challenging to detect until it is advanced. Regular monitoring and management are essential for transplant recipients to help reduce the risk of CAV and maintain heart health.